LatInamerican Vaccine Effectiveness against hospitalizations due to circulating COVID-19 VoC RWE study

Trial Identifier: D8111R00016
Sponsor: AstraZeneca
NCTID:: NCT05282017
Start Date: February 2022
Primary Completion Date: March 2023
Study Completion Date: March 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Argentina, Buenos Aires Argentina, Buenos Aires, Argentina, 1407
Argentina, Buenos Aires Argentina, Buenos Aires, Argentina, 1425
Argentina, CABA Argentina, CABA, Argentina, 1181
Brazil, Rio de Janeiro Brazil, Rio de Janeiro, Brazil, 22211-230
Brazil, Salvador Brazil, Salvador, Brazil, 41253-190
Brazil, Sao Paulo Brazil, Sao Paulo, Brazil, 04501-000
Colombia, Colombia Bogota, Colombia, Colombia, 1102
Colombia, Colombia Cali, Colombia, Colombia, 760004
Costa Rica, Costa Rica San Jose, Costa Rica, Costa Rica, 10108
Mexico, Jalisco Guadalajara, Jalisco, Mexico, 44280
Mexico, Yucatan Merida, Yucatan, Mexico, 97000
Panama, Panama Panama, Panama, 0843-01103